Jipmer has launched a comprehensive Universal Newborn Screening (NBS) programme and a dedicated laboratory to identify serious congenital disorders in newborns shortly after birth. This initiative aims to prevent irreversible complications through early detection.

Key Takeaways

  • Jipmer inaugurated the Universal Newborn Screening (NBS) programme and a specialized lab.
  • The program targets metabolic, endocrine, and other congenital disorders.
  • Testing involves a simple heel-prick procedure to collect dried blood spot samples.
  • Early intervention can prevent intellectual disability and developmental delays.

Puducherry: The Jawaharlal Institute of Postgraduate Medical Education and Research (Jipmer) has reached a significant milestone in neonatal healthcare by launching the Universal Newborn Screening (NBS) programme. Accompanied by a state-of-the-art NBS laboratory, the initiative aims to screen every eligible newborn delivered at the institute for congenital disorders immediately after birth.

The programme was officially inaugurated by Saka Vinod Kumar, Medical Superintendent of Jipmer. The specialized laboratory is designed to process dried blood spot (DBS) samples using standardized, high-quality protocols to ensure rapid and reliable results.

Why This Matters

BozokMedia analysis shows that many life-altering genetic and metabolic conditions are asymptomatic at birth. Without proactive screening, these disorders often go undetected until irreversible damage, such as organ dysfunction or intellectual disability, has already occurred. This programme bridges that critical diagnostic gap.

Universal newborn screening transforms child healthcare by enabling early identification of disorders that are often treatable if caught in the neonatal period.

Vir Singh Negi, Director of Jipmer, emphasized that this programme aligns with the institute's vision of expanding preventive services for the most vulnerable populations. Furthermore, Nisha Plakkal, Head of Neonatology, noted that many affected newborns appear completely healthy at birth, making clinical examination alone insufficient for diagnosis.

Historical Background

Globally, newborn screening has become a gold standard in public health. By identifying metabolic and endocrine disorders early, healthcare systems have drastically reduced infant mortality and long-term disability rates. Jipmer's move brings this advanced preventive standard to the forefront of regional medical services.

Did You Know?: Some metabolic disorders can lead to permanent brain damage within days of birth if not treated immediately, even if the baby looks perfectly healthy.

Frequently Asked Questions

1. How is the blood sample collected from the baby?
The sample is collected through a simple, minimally invasive heel-prick procedure to obtain a dried blood spot.

2. What happens if a newborn tests positive for a disorder?
The programme includes prompt reporting, confirmatory investigations, and the immediate initiation of treatment by a multidisciplinary medical team.